COVID-19 vaccines: anaphylaxis and anxiety : A case study from an allergy unit.

Andrea R TeufelbergerAndrada-Renata DanLinda IrmlerPeter WolfBirger Kränke

Published in: Wiener klinische Wochenschrift (2024)

Anxiety about another anaphylactoid episode hinders patients to be vaccinated against SARS-CoV‑2 again. Premedication with antihistamines and collaboration of allergologists with psychologists might lower the risk of an anaphylactic/anaphylactoid response as well anxiety in drug-induced anaphylactic patients.

Keyphrases

sars cov
end stage renal disease
drug induced
newly diagnosed
ejection fraction
chronic kidney disease
liver injury
coronavirus disease
peritoneal dialysis
prognostic factors
sleep quality
respiratory syndrome coronavirus
physical activity
patient reported